Literature DB >> 12220504

Interaction of plexin-B1 with PDZ domain-containing Rho guanine nucleotide exchange factors.

Mutsumi Hirotani1, Yoshiharu Ohoka, Takahiro Yamamoto, Hiromi Nirasawa, Tatsuo Furuyama, Mikihiko Kogo, Tokuzo Matsuya, Shinobu Inagaki.   

Abstract

The Rho family GTPase has been implicated in plexin-B1, a receptor for Semaphorin 4D (Sema4D), mediating signal transduction. Rho may also play a function in this signaling pathway as well as Rac, but the mechanisms for Rho regulation are poorly understood. In this study, we have identified two kinds of PDZ domain-containing Rho-specific guanine nucleotide exchange factors (RhoGEFs) as proteins interacting with plexin-B1 cytoplasmic domain. These PDZ domain-containing RhoGEFs showed significant homology to human KIAA0380 (PDZ-RhoGEF) and LARG (KIAA0382), respectively. Both KIAA0380 and LARG could bind plexin-B1 and a deletion mutant analysis of plexin-B1, KIAA0380 and LARG revealed that KIAA0380 and LARG bound plexin-B1 cytoplasmic tail through their PDZ domains. The tissue distribution analysis indicated that plexin-B1 was co-localized with KIAA0380 and LARG in various tissues. Immunocytochemical analysis showed that LARG was recruited to plasma membrane by plexin-B1. These results suggest that PDZ domain-containing RhoGEFs play a role in Sema4D-plexin-B1 mediating signal transduction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12220504     DOI: 10.1016/s0006-291x(02)02122-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  31 in total

1.  Identification of a novel sequence in PDZ-RhoGEF that mediates interaction with the actin cytoskeleton.

Authors:  Jayashree Banerjee; Philip B Wedegaertner
Journal:  Mol Biol Cell       Date:  2004-01-23       Impact factor: 4.138

Review 2.  Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer.

Authors:  Atsuko Sakurai; Colleen L Doçi; Colleen Doci; J Silvio Gutkind
Journal:  Cell Res       Date:  2011-12-13       Impact factor: 25.617

Review 3.  R-ras as a key player for signaling pathway of plexins.

Authors:  Manabu Negishi; Izumi Oinuma; Hironori Katoh
Journal:  Mol Neurobiol       Date:  2005-12       Impact factor: 5.590

Review 4.  Regulation and physiological functions of G12/13-mediated signaling pathways.

Authors:  Nobuchika Suzuki; Nicole Hajicek; Tohru Kozasa
Journal:  Neurosignals       Date:  2009-02-12

Review 5.  Structure and function of heterotrimeric G protein-regulated Rho guanine nucleotide exchange factors.

Authors:  Mohamed Aittaleb; Cassandra A Boguth; John J G Tesmer
Journal:  Mol Pharmacol       Date:  2009-10-30       Impact factor: 4.436

Review 6.  Signalling mechanisms of RhoGTPase regulation by the heterotrimeric G proteins G12 and G13.

Authors:  Tohru Kozasa; Nicole Hajicek; Christina R Chow; Nobuchika Suzuki
Journal:  J Biochem       Date:  2011-08-26       Impact factor: 3.387

7.  Binding of PDZ-RhoGEF to ATP-binding cassette transporter A1 (ABCA1) induces cholesterol efflux through RhoA activation and prevention of transporter degradation.

Authors:  Keiichiro Okuhira; Michael L Fitzgerald; Norimasa Tamehiro; Nobumichi Ohoka; Kazuhiro Suzuki; Jun-ichi Sawada; Mikihiko Naito; Tomoko Nishimaki-Mogami
Journal:  J Biol Chem       Date:  2010-03-26       Impact factor: 5.157

Review 8.  Semaphorins and plexins as therapeutic targets.

Authors:  Thomas Worzfeld; Stefan Offermanns
Journal:  Nat Rev Drug Discov       Date:  2014-08       Impact factor: 84.694

9.  Regulated localization is sufficient for hormonal control of regulator of G protein signaling homology Rho guanine nucleotide exchange factors (RH-RhoGEFs).

Authors:  Angela M Carter; Stephen Gutowski; Paul C Sternweis
Journal:  J Biol Chem       Date:  2014-05-22       Impact factor: 5.157

10.  Unc5B associates with LARG to mediate the action of repulsive guidance molecule.

Authors:  Katsuhiko Hata; Kozo Kaibuchi; Shinobu Inagaki; Toshihide Yamashita
Journal:  J Cell Biol       Date:  2009-03-09       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.